Subscribe to a Global-Regulation Premium Membership Today!

240. Ordinance of the Federal Minister of Health, with which the prescription of the prescription of the prescription is changed

On the basis of § 2 para. 1 prescription law, BGBl. No 413/1972, as last amended by the Federal Law BGBl. I n ° 115/2008 and the Federal Ministries of the Federal Ministries of Law 2009, BGBl. I No 3, shall be assigned:

The prescription decree, BGBl. No 475/1973, as last amended by BGBl. II No 183/2009, shall be amended as follows:

The list of Annex A. Medicinal products for human use, part 2 human, shall be supplemented at the appropriate alphabetical points as follows:

ABARELIX NO

AGOMELATIN NO

5-Aminolaevulinic acid RP

AZACITIDIN NO

BAZEDOXIFEN NO

BILASTIN RP

CANAKINUMAB NO

CATUMAXOMAB NO

CERTOLIZUMAB NO

DAPOXETIN NO

DEGARELIX NO

EPOETIN THETA NO

ESLICARBAZEPIN RP

GEFITINIB NO

GOLIMUMAB NO

HISTRELIN NO

LASOFOXIFEN NO

LIRAGLUTID NO

MIFAMURTID NO

PLERIXAFOR NO

PRASUGREL RP

PRUCALOPRIDE RP

RILONACEPT NO

ROMIPLOSTIM NO

SAPROPTERIN NO

SAXAGLIPTIN NO

TOCILIZUMAB NO

TOCOFERSOLAN RP

TOLVAPTAN NO

ULIPRISTAL RP

STEKINUMAB NO

VINFLUNIN NO

The list of Annex A. Medicinal products for human use, part 2 human, shall be amended as follows:

FEXOFENADIN RP

is replaced by

FEXOFENADIN RPF

NAPHAZOLIN RP, R86, Ryy, W1

is replaced by

NAPHAZOLIN RP, R86, R93, W1

PROPYPHENAZON RPF, W 7, W 17

is replaced by

PROPYPHENAZON RP

PANTOPRAZOLE RP

is replaced by

PANTOPRAZOLE RP, R97

TYLOXAPOL RP

is deleted

3. Annex I to Annex A. Medicinal products for human use shall be included in the following collection of products:

R 97 excluded for the short-term treatment of reflux symptoms (e. g. heartburn, acid refluxing) in adults up to 20 mg per day

The list of Annex B. Veterinary medicinal products, part 2 veterinarian, shall be supplemented at the appropriate alphabetical points as follows:

MASITINIB NO

PEFORELIN RP

ROBENACOXIB RP

TOCERANIB NO